A new study suggests that an epilepsy drug could help alleviate symptoms of obstructive sleep apnoea, a common condition affecting about 5% of people. Presented at the European Respiratory Society Congress in Vienna, the research indicates that the drug sulthiame may significantly reduce breathing interruptions and improve oxygen levels during sleep. Obstructive sleep apnoea, which causes frequent interruptions in breathing during sleep, is often treated with mechanical devices like CPAP machines. However, many patients struggle with these devices, prompting the search for alternative treatments. The international study involved nearly 300 patients across Belgium, the Czech Republic, France, Germany, and Spain, who were either given sulthiame at varying doses or a placebo. After 12 weeks, those on sulthiame experienced up to 50% fewer breathing pauses and higher blood oxygen levels compared to those on the placebo. The most significant benefits were observed with the highest doses of the drug. Source: Oman News Agency
Related Articles
China’s International Trade in Goods, Services Hits USD592 Billion in March
Beijing: The value of China’s international trade in goods and services reached 4.27 trillion yuan (about USD592.57 billion) in March 2025, up 6% year-on-year, official data showed.
According to Oman News Agency, of the total, the export of goods st…
Increased Allocations for Governorate Development Underscore Royal Care to Social Welfare
Muscat: The Royal directives to increase the allocations for the Governorate Development Program to RO 270 million during the Eleventh Five-Year Development Plan (2026-2030) confirms the Royal care to enhance social welfare and ensure balanced develop…
Bahrain All Share Index marks 2,017.15 points
Manama: Bahrain All Share Index has closed at 2,017.15 points, marking a decrease of 8.34 points below the previous closing.
This decrease was due to the drop in the communication services sector, the financial sector and the material sector.
Bahrai…
